Digital Library
Close Browse articles from a journal
 
Search for with title:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             198 results found
no title author magazine year volume issue page(s) type
1 Ability of monoclonal antibody to herpes simplex virus glycoprotein gB to promote healing of herpetic skin lesions in nude mice Yamamoto, Masahiro
 1986
 4 p. 223-231
9 p.
 article
2 A colorimetric assay for the measurement of the sensitivity of herpes simplex viruses to antiviral agents McLaren, C.
 1983
 4 p. 223-234
12 p.
 article
3 A comparison of phosphonoacetic acid and phosphonoformic acid activity in genital herpes simplex virus type 1 and type 2 infections of mice Kern, Earl R.
 1981
 4 p. 225-235
11 p.
 article
4 Activated interferon system in healthy homosexual men Levin, S.
 1985
 4 p. 229-240
12 p.
 article
5 Acyclovir — A review of the preclinical and early clinical data of a new antiherpes drug Brigden, D.
 1981
 4 p. 203-212
10 p.
 article
6 Acyclovir treatment of disseminated herpes simplex virus type 2 infection in weanling mice: Alteration of mortality and pathogenesis Kern, Earl R.
 1986
 4 p. 189-195
7 p.
 article
7 Acyclovir treatment of experimental genital herpes simplex virus infections. I. Topical therapy of type 2 and type 1 infections of mice Kern, Earl R.
 1983
 4 p. 253-267
15 p.
 article
8 AIDS: Questions and answers Schellekens, H.
 1986
 4 p. 253-
1 p.
 article
9 A ‘new’ generation of more potent synthetic antirhinovirus compounds: comparison of their MICs and their synergistic interactions Al-Nakib, Widad
 1987
 4 p. 179-187
9 p.
 article
10 Animal models for antiviral chemotherapy Field, H.J.
 1989
 4 p. 165-180
16 p.
 article
11 An in vitro study of ophthalmic antiviral agent toxicity on rabbit corneal epithelium Imperia, Paul S.
 1988
 4 p. 263-272
10 p.
 article
12 Announcement 1995
 4 p. 380-
1 p.
 article
13 Announcement 1985
 4 p. 257-
1 p.
 article
14 Announcement 1989
 4 p. 216-
1 p.
 article
15 Announcement 1983
 4 p. 285-
1 p.
 article
16 Announcement 1984
 4 p. 229-
1 p.
 article
17 Announcement of 3 cancer meetings 1988
 4 p. 281-282
2 p.
 article
18 Announcements 1987
 4 p. 223-224
2 p.
 article
19 A novel method for detecting the antiviral activity of flavans in their vapour phase Bauer, D.J.
 1983
 4 p. 235-239
5 p.
 article
20 Antiherpes activity of chemically synthesized lipid A-subunit analogue GLA-60 in immunosuppressed mice Ikeda, Satoru
 1989
 4 p. 173-180
8 p.
 article
21 Antiherpes activity of [E]-5-(1-propenyl)-2′-deoxyuridine and 5-(1-propenyl)-1-β-d-arabinofuranosyluracil Stening, G.
 1981
 4 p. 213-223
11 p.
 article
22 Anti-human cytomegalovirus activity and toxicity of sulfonated anthraquinones and anthraquinone derivatives Barnard, D.L.
 1995
 4 p. 317-329
13 p.
 article
23 Antisense inhibitors of HIV: Problems and perspectives Degols, Geneviève
 1992
 4 p. 279-287
9 p.
 article
24 Antiviral action of 5-amino-2-(2-dimethylaminoethyl)benzo-[de]-isoquinolin-1,3-dione Gancedo, Angel García
 1984
 4 p. 201-210
10 p.
 article
25 Antiviral activity of selected acyclic nucleoside analogues against human herpesvirus 6 Reymen, D.
 1995
 4 p. 343-357
15 p.
 article
26 Antiviral activity of the prostanoid clavulone II against vesicular stomatitis virus Bader, Th.
 1991
 4 p. 341-355
15 p.
 article
27 Antiviral effect of the extract of culture medium of Lentinus edodes mycelia on the replication of herpes simplex virus type 1 Sarkar, S.
 1993
 4 p. 293-303
11 p.
 article
28 Antiviral effect of two aryl-oligopeptides, FR41565 and FR48217 Oku, Tohru
 1986
 4 p. 233-239
7 p.
 article
29 Antiviral effects of dihydroxypropyladenine ((RS)-DHPA) and bromovinyldeoxyuridine (BVDU) on plant viruses De Fazio, G.
 1987
 4 p. 163-169
7 p.
 article
30 Antiviral effects of recombinant human tumor necrosis factor-alpha in combination with natural interferon-beta in mice infected with herpes simplex virus type 1 Schmitt, David A.
 1992
 4 p. 347-352
6 p.
 article
31 Antiviral effects of single-stranded polynucleotide inhibitors of the influenza virion-associated transcriptase against influenza virus infection of hamsters and ferrets Round, Elizabeth M.
 1981
 4 p. 237-248
12 p.
 article
32 Antiviral properties of Ro 31-8959, an inhibitor of human immunodeficiency virus (HIV) proteinase Craig, J.C.
 1991
 4 p. 295-305
11 p.
 article
33 Antiviral resistance — an emerging problem Kimberlin, David W.
 1995
 4 p. 365-368
4 p.
 article
34 Antiviral resistance in clinical practice Kimberlin, David W.
 1995
 4 p. 423-438
16 p.
 article
35 Aryl phosphate derivatives of AZT retain activity against HIV1 in cell lines which are resistant to the action of AZT McGuigan, Christopher
 1992
 4 p. 311-321
11 p.
 article
36 Assays for antiviral drug resistance Kimberlin, David W.
 1995
 4 p. 403-413
11 p.
 article
37 Author index 1995
 4 p. 369-371
3 p.
 article
38 Author index 1995
 4 p. 453-454
2 p.
 article
39 Author index 1995
 4 p. 431-434
4 p.
 article
40 Author index 1991
 4 p. 361-363
3 p.
 article
41 Author index 1993
 4 p. 333-334
2 p.
 article
42 Author index 1992
 4 p. 353-355
3 p.
 article
43 Author index 1992
 4 p. 363-365
3 p.
 article
44 Author index 1993
 4 p. 349-351
3 p.
 article
45 Author index 1993
 4 p. 371-373
3 p.
 article
46 Author index 1991
 4 p. 349-351
3 p.
 article
47 Author index 1994
 4 p. 367-369
3 p.
 article
48 A vaccine against Semliki Forest virus consisting of a monoclonal anti-idiotypic antibody cross-linked to a protein which contains virus-specific T-helper cell epitopes Kraaijeveld, C.A.
 1992
 4 p. 275-284
10 p.
 article
49 Bicyclic imidazo derivatives, a new class of highly selective inhibitors for the human immunodeficiency virus type 1 Moog, Christiane
 1994
 4 p. 275-288
14 p.
 article
50 Bovine interferon: Its biology and application in veterinary medicine Ohmann, H.Bielefeldt
 1987
 4 p. 187-210
24 p.
 article
51 Challenges in the clinical development of antiretroviral drugs Schooley, Robert T.
 1992
 4 p. 305-310
6 p.
 article
52 Characterization of the non-specific humoral and cellular antiviral immunity stimulated by the chloroform-methanol residue (CMR) fraction of Coxiella burnetii Zvilich, Menachem
 1995
 4 p. 389-404
16 p.
 article
53 Combined antiviral effects of acyclovir or bromovinyldeoxyuridine and human immunoglobulin in herpes simplex virus-infected mice Hilfenhaus, Joachim
 1987
 4 p. 227-235
9 p.
 article
54 Comparative anti-influenza virus activity of 2′-deoxy-2′-fluororibosides in vitro Rollins, Barbara S.
 1993
 4 p. 357-368
12 p.
 article
55 Comparison of the in vitro and in vivo anti-herpes activities of 1-β-d-arabinofuranosylthymine and its 5′-monophosphate Machida, Haruhiko
 1982
 4 p. 217-226
10 p.
 article
56 Complementary oligonucleotide sequence inhibits both Vmw65 gene expression and replication of herpes simplex virus Draper, Kenneth G.
 1990
 4 p. 151-164
14 p.
 article
57 Contents of volume 28 1995
 4 p. 377-379
3 p.
 article
58 Contents of volume 26 1995
 4 p. 458-460
3 p.
 article
59 Contents of volume 22 1993
 4 p. 339-341
3 p.
 article
60 Contents of volume 20 1993
 4 p. 357-359
3 p.
 article
61 Contents of volume 16 1991
 4 p. 357-359
3 p.
 article
62 Contents of volume 19 1992
 4 p. 371-373
3 p.
 article
63 Contents of volume 17 1992
 4 p. 349-351
3 p.
 article
64 Contents of volume 21 1993
 4 p. 379-381
3 p.
 article
65 Contents of volume 27 1995
 4 p. 439-442
4 p.
 article
66 Contents of volume 15 1991
 4 p. 345-348
4 p.
 article
67 Contents of volume 24 1994
 4 p. 373-375
3 p.
 article
68 Cytomegalovirus infection in immunocompromised guinea pigs: A model for testing antiviral agents in vivo Aquino-de Jesus, Mary Janette C.
 1989
 4 p. 181-193
13 p.
 article
69 Development of age-dependent resistance to sindbis virus encephalitis: Correlation with inactivation of virus within the blood stream Hirsch, Robert L.
 1981
 4 p. 263-267
5 p.
 article
70 Didanosine (ddI) and zidovudine (ZDV) susceptibilities of human immunodeficiency virus (HIV) isolates from long-term recipients of ddI Reichman, Richard C.
 1993
 4 p. 267-277
11 p.
 article
71 Didemnins A and B. Effectiveness against cutaneous herpes simplex virus in mice Weed, Sheldon D.
 1983
 4 p. 269-274
6 p.
 article
72 Differential expression patterns of type I interferon subtypes in mouse embryo fibroblasts: Influence of genotype and viral inducer Lai, May C.
 1994
 4 p. 327-340
14 p.
 article
73 Differential inhibition of reverse transcriptase and cellular DNA polymerase-α activities by lignans isolated from Chinese herbs, Phyllanthus myrtifolius Moon, and tannins from Lonicera japonica Thunb and Castanopsis hystrix Chang, Chia-Wen
 1995
 4 p. 367-374
8 p.
 article
74 Differential reconstitution of zidovudine-induced inhibition of mitogenic responses by interleukin-2 in peripheral blood mononuclear cells from patients with human immunodeficiency virus infection Nokta, Mostafa A.
 1989
 4 p. 191-202
12 p.
 article
75 Different pattern of activity of inhibitors of the human immunodeficiency virus in lymphocytes and monocyte/macrophages Perno, Carlo-Federico
 1992
 4 p. 289-304
16 p.
 article
76 Drug testing for activity against varicella-zoster virus in hairless guinea pigs Myers, Martin G.
 1991
 4 p. 341-344
4 p.
 article
77 Editorial 1981
 4 p. 201-202
2 p.
 article
78 Effect of 3′azidothymidine administered in drinking water or by continuous infusion on the development of MAIDS Eiseman, J.L.
 1991
 4 p. 307-326
20 p.
 article
79 Effect of CP-20,961 on genital herpes in guinea pigs Zheng, Zhi-Ming
 1983
 4 p. 275-283
9 p.
 article
80 Effect of human, recombinant interleukin 2 on Punta Toro virus infections in C57BL/6 mice Mead, Jan R.
 1991
 4 p. 331-340
10 p.
 article
81 Effect of N-methylisatin-β-4′:4′-diethylthiosemicarbazone on intracellular Moloney leukemia virus constituents Ronen, Dvora
 1985
 4 p. 249-254
6 p.
 article
82 Effects of acyclovir therapy during simultaneous reactivation of latent HSV-1 in rabbits Demangone, Michael
 1987
 4 p. 237-243
7 p.
 article
83 Effects of cytokines and R-837, a cytokine inducer, on UV-irradiation augmented recurrent genital herpes in guinea pigs Harrison, Christopher J.
 1991
 4 p. 315-322
8 p.
 article
84 Effects of human and murine interferons against hemorrhagic fever with renal syndrome (HFRS) virus (Hantaan virus) Tamura, Manabu
 1987
 4 p. 171-178
8 p.
 article
85 Effects of tumor necrosis factor-α treatment on mortality in murine cytomegalovirus-infected mice Anderson, Kevin P.
 1993
 4 p. 343-355
13 p.
 article
86 Efficacy of ganciclovir in combination with zidovudine against cytomegalovirus in vitro and in vivo Freitas, Vicki R.
 1993
 4 p. 301-315
15 p.
 article
87 Efficacy of high dose-short duration ribavirin aerosol in the treatment of respiratory syncytial virus infected cotton rats and influenza B virus infected mice Wyde, Philip R.
 1987
 4 p. 211-220
10 p.
 article
88 Enhancement of non-specific resistance to viral infection by muramyldipeptide and its analogs Ikeda, Satoru
 1985
 4 p. 207-215
9 p.
 article
89 Erratum 1994
 4 p. 365-
1 p.
 article
90 Estrogen suppresses hepatitis B virus expression in male athymic mice transplanted with HBV transfected Hep G-2 cells Almog, Yaniv
 1992
 4 p. 285-293
9 p.
 article
91 Evaluation of (E)-5-(2-bromovinyl)- and 5-vinyl-1-β-D-arabinofuranosyluracil (BrVaraU, VaraU) in the treatment of experimental herpes simplex virus type 1 keratitis in rabbits: Comparison with (E)-5-(2-bromovinyl)-2′-deoxyuridine (BrVUdR) Töpke, H.
 1988
 4 p. 273-280
8 p.
 article
92 Evaluation of multiple parameters of HIV-1 replication cycle in testing of AIDS drugs in vitro Volsky, David J.
 1992
 4 p. 335-347
13 p.
 article
93 Evaluation of the anti-herpesvirus drug combinations: Virazole plus arabinofuranosylhypoxanthine and Virazole plus arabinofuranosyladenine Allen, Lois B.
 1982
 4 p. 203-216
14 p.
 article
94 Evidence that the amino acid region 124–203 of glycoprotein G from the respiratory syncytial virus (RSV) constitutes a major part of the polypeptide domain that is involved in the protection against RSV infection Simard, Claire
 1995
 4 p. 303-315
13 p.
 article
95 Feline calicivirus subunit vaccine - a prototype Komolafe, O.O.
 1985
 4 p. 241-248
8 p.
 article
96 Feline immunodeficiency virus infection of cats as a model to test the effect of certain in vitro selection pressures on the infectivity and virulence of resultant lentivirus variants Barlough, Jeffrey E.
 1993
 4 p. 259-272
14 p.
 article
97 Final announcement of the second international TNO meeting on the biology of the interferon system 1982
 4 p. 241-
1 p.
 article
98 Herpes simplex virus as an inducer of interferon in human monocyte cultures Linnavuori, Kimmo
 1987
 4 p. 201-208
8 p.
 article
99 Herpes simplex virus glycoprotein immunotherapy of recurrent genital herpes: Factors influencing efficacy Stanberry, Lawrence R.
 1989
 4 p. 203-214
12 p.
 article
100 Highly potent and selective inhibition of HIV-1 replication by 6-phenylthiouracil derivatives Baba, Masanori
 1992
 4 p. 245-264
20 p.
 article
101 Human acid- and thermolabile α-interferon-like substance: Selective reactivity with a monoclonal antibody Borecký, L.
 1989
 4 p. 195-203
9 p.
 article
102 Hydrocephalus induction in mice infected with herpes simplex virus type 2 after antiviral treatment Schinazi, Raymond F.
 1995
 4 p. 291-302
12 p.
 article
103 II In response to Prichard and Shipman's letter to the editor regarding the paper: Efficacy of ganciclovir in combination with zidovudine against cytomegalovirus in vitro and in vivo Fraser-Smith, Elizabeth B.
 1994
 4 p. 361-364
4 p.
 article
104 I Letter to the editor in response to the paper: Efficacy of ganciclovir in combination with zidovudine against cytomegalovirus in vitro and in vivo Prichard, Mark N.
 1994
 4 p. 357-359
3 p.
 article
105 Increased efficacy of ganciclovir in combination with foscarnet against cytomegalovirus and herpes simplex virus type 2 in vitro and in vivo Freitas, Vicki R.
 1989
 4 p. 205-212
8 p.
 article
106 Induction of a refractory state to viral infection in mammalian cells by a plant inhibitor isolated from leaves of Melia azedarach L Andrei, Graciela M.
 1988
 4 p. 221-231
11 p.
 article
107 Inhibition of hepatitis delta virus RNA replication in primary woodchuck hepatocytes Choi, Sung-Su
 1989
 4 p. 213-222
10 p.
 article
108 Inhibition of human adenoviruses by 1-(2′-hydroxy-5′-methoxybenzylidene)amino-3-hydroxyguanidine tosylate Hui, M.B.V.
 1994
 4 p. 261-273
13 p.
 article
109 Inhibition of human and woodchuck hepatitis virus DNA polymerase by the triphosphates of acyclovir, 1-(2′-deoxy-2′-fluoro-β-d-arabinofuranosyl)-5-iodocytosine and E-5-(2-bromovinyl)-2′-deoxyuridine Hantz, O.
 1984
 4 p. 187-199
13 p.
 article
110 Inhibition of human immunodeficiency virus by N-methylisatin-β4′:4′-diethylthiosemicarbazone and N-allylisatin-β-4′:4′-diallythiosemicarbazone Teitz, Y.
 1994
 4 p. 305-314
10 p.
 article
111 Inhibition of human immunodeficiency virus type 1 wild-type and mutant reverse transcriptases by the phenyl ethyl thiazolyl thiourea derivatives trovirdine and MSC-127 Zhang, Hong
 1995
 4 p. 331-342
12 p.
 article
112 Inhibition of neurotropic mouse retrovirus replication in glial cells by synthetic oligo(2′-O-methyl)ribonucleoside phosphorothioates Takase-Yoden, Sayaka
 1995
 4 p. 359-368
10 p.
 article
113 Inhibition of Simian varicella virus infection of monkeys by 1-(2-deoxy-2-fluoro-1-β-d-arabinofuranosyl)-5-ethyluracil (FEAU) and synergistic effects of combination with human recombinant interferon-β Soike, Kenneth F.
 1990
 4 p. 165-174
10 p.
 article
114 Inhibition of the enteroviruses that cause acute hemorrhagic conjunctivitis (AHC) by benzimidazoles; Enviroxime (LY 122772) and Enviradone (LY 127123) Langford, M.P.
 1995
 4 p. 355-365
11 p.
 article
115 Inhibition of the growth of influenza viruses in vitro by 4-guanidino-2,4-dideoxy-N-acetylneuraminic acid Thomas, G.P.
 1994
 4 p. 351-356
6 p.
 article
116 Inhibition of the infectivity of influenza virus by tea polyphenols Nakayama, Mikio
 1993
 4 p. 289-299
11 p.
 article
117 Inhibitory activity of the new adamantane derivative N,N′-bis(ethylene)-P (1-adamantyl)-phosphonic diamide against rous sarcoma virus McGraw, Thomas L.
 1981
 4 p. 269-272
4 p.
 article
118 Inhibitory effect of bafilomycin A1, a specific inhibitor of vacuolar-type proton pump, on the growth of influenza A and B viruses in MDCK cells Ochiai, Hiroshi
 1995
 4 p. 425-430
6 p.
 article
119 Interference with HIV-1 reverse transcriptase-catalyzed DNA chain elongation by the 5′-triphosphate of the carbocyclic analog of 2′-deoxyguanosine Parker, William B.
 1992
 4 p. 325-332
8 p.
 article
120 International symposium on california serogroup viruses 1982
 4 p. 241-
1 p.
 article
121 In vitro activity of a Combretum micranthum extract against herpes simplex virus types 1 and 2 Ferrea, Giuseppe
 1993
 4 p. 317-325
9 p.
 article
122 In vitro antiviral activity of polyoxomolybdates. Mechanism of inhibitory effect of PM-104 (NH4)12H2(Eu4(MoO4(H2O)16(Mo7O24)4) · 13H2O on human immunodeficiency virus type 1 Inouye, Yoshio
 1993
 4 p. 317-331
15 p.
 article
123 In vitro antiviral activity of polyoxotungstate (PM-19) and other polyoxometalates against herpes simplex virus Fukuma, Mariko
 1991
 4 p. 327-339
13 p.
 article
124 In vitro effect of synthetic flavanoids on astrovirus infection Superti, Fabiana
 1990
 4 p. 201-208
8 p.
 article
125 In vitro inhibition of human cytomegalovirus replication in human foreskin fibroblasts and endothelial cells by ascorbic acid 2-phosphate Cinatl, Jindrich
 1995
 4 p. 405-418
14 p.
 article
126 In vivo and in vitro hamster models in the assessment of virulence of recombinant influenza viruses Heath, A.W.
 1983
 4 p. 241-252
12 p.
 article
127 IXth international conference on AIDS in affiliation with the IVth STD world congress Berlin, June 7–11, 1993 1993
 4 p. 347-
1 p.
 article
128 IXth international congress of virology Glasgow, Scotland, 8–13 August 1993 1992
 4 p. 361-
1 p.
 article
129 Lack of synergy in the inhibition of HIV-1 reverse transcriptase by combinations of the 5′-triphosphates of various anti-HIV nucleoside analogs White, E.Lucile
 1993
 4 p. 295-308
14 p.
 article
130 Main properties of duck hepatitis B virus DNA polymerase: comparison with the human and woodchuck hepatitis B virus DNA polymerases Fourel, I.
 1987
 4 p. 189-199
11 p.
 article
131 Mechanism of action of the antiviral compound MDL 20,610 Kenny, Michael T.
 1988
 4 p. 249-261
13 p.
 article
132 Mechanism of antiviral action of quercetin against cardiovirus infection in mice Veckenstedt, Anneliese
 1981
 4 p. 249-261
13 p.
 article
133 Metal chelators as potential antiviral agents Hutchinson, D.W.
 1985
 4 p. 193-205
13 p.
 article
134 β 2-Microglobulin and antiviral therapy for chronic hepatitis type B de Man, R.A.
 1989
 4 p. 181-190
10 p.
 article
135 Models of antiviral resistance Kimberlin, David W.
 1995
 4 p. 415-422
8 p.
 article
136 Modification of experimental rhinovirus colds by receptor blockade Hayden, Frederick G.
 1988
 4 p. 233-247
15 p.
 article
137 Modification of immunological responses and clinical disease during topical R-387 treatment of genital HSV-2 infection 1989
 4 p. 215-
1 p.
 article
138 Molecular mechanisms of antiviral resistance Kimberlin, David W.
 1995
 4 p. 369-401
33 p.
 article
139 Monitoring of ganciclovir sensitivity of multiple human cytomegalovirus strains coinfecting blood of an AIDS patient by an immediate-early antigen plaque assay Gerna, Giuseppe
 1992
 4 p. 333-345
13 p.
 article
140 Murine cytomegalovirus-inhibitory effects of ImuVert Sidwell, Robert W.
 1993
 4 p. 279-292
14 p.
 article
141 Natural antiviral activity of mouse macrophages against encephalomyocarditis virus Soldateschi, Dario
 1985
 4 p. 217-227
11 p.
 article
142 Novel indolocarbazole protein kinase C inhibitors prevent reactivation of HIV-1 in latently infected cells Pätzold, Susanne
 1993
 4 p. 273-283
11 p.
 article
143 Novel sulfonated and phosphonated analogs of distamycin which inhibit the replication of HIV Clanton, David J.
 1995
 4 p. 335-354
20 p.
 article
144 Pharmacokinetics of zidovudine and didanosine during combination therapy Morse, Gene D.
 1995
 4 p. 419-424
6 p.
 article
145 Physical and biological characterization of antigen presenting liposome formulations: Relative efficacy for the treatment of recurrent genital HSV-2 in guinea pigs Ho, Rodney J.Y.
 1990
 4 p. 187-199
13 p.
 article
146 Potentiating effect of murine interferon-γ-containing lymphokine preparations on the antiviral and antiproliferative effects of murine interferon-α/β: identification of the potentiation factor as murine interferon-γ itself Fleischmann Jr., W.Robert
 1984
 4 p. 221-228
8 p.
 article
147 Potentiating effect of ribavirin on the anti-retrovirus activity of 3′-azido-2,6-diaminopurine-2′,3′-dideoxyriboside in vitro and in vivo Balzarini, Jan
 1989
 4 p. 161-171
11 p.
 article
148 Pulmonary catabolism of interferons: alveolar absorption of 125I-labeled human interferon alpha is accompanied by partial loss of biological activity Bocci, V.
 1984
 4 p. 211-220
10 p.
 article
149 Quercetin potentiates TNF-induced antiviral activity Ohnishi, Eiko
 1993
 4 p. 327-331
5 p.
 article
150 Recent advances in the design of HIV proteinase inhibitors Martin, Joseph A.
 1992
 4 p. 265-278
14 p.
 article
151 Recombinant interferons alpha and gamma: comparative antiviral activity and synergistic interaction in encephalomyocarditis virus infection of mice Sim, Iain S.
 1987
 4 p. 209-221
13 p.
 article
152 Regulatory effects of deoxyribonucleosides on the activity of 5-methoxymethyl-2′-deoxycytidine: Modulation of antiherpes activity by deoxyguanosine and tetrahydrodeoxyuridine Aduma, Philip J.
 1991
 4 p. 301-313
13 p.
 article
153 Related elsevier titles contents alert 1993
 4 p. 383-384
2 p.
 article
154 Related elsevier virology titles contents alert 1995
 4 p. I-III
nvt p.
 article
155 Related Elsevier virology titles contents alert 1993
 4 p. i-iii
nvt p.
 article
156 Relevance of DNA binding to the mechanism of anti-herpesvirus activity of benzhydrazone Palu′, Giorgio
 1993
 4 p. 305-316
12 p.
 article
157 Research initiatives in studies of antiviral resistance and consensus points and recommendations Kimberlin, David W.
 1995
 4 p. 439-452
14 p.
 article
158 Response of Ethiopian human immunodeficiency virus type 1 isolates to antiviral compounds Wondimu, Zenebech
 1992
 4 p. 353-359
7 p.
 article
159 Reversal of the antiviral activity of ribavirin against Sindbis virus in Ae. albopictus mosquito cells Liao, Huey-Jane
 1993
 4 p. 285-294
10 p.
 article
160 Ribavirin efficacy in an in vivo model of Crimean-Congo hemorrhagic fever virus (CCHF) infection Tignor, Gregory H.
 1993
 4 p. 309-325
17 p.
 article
161 Selective inhibitory effects of (S)-9-(3-hydroxy-2-phosphonyl-methoxypropyl) adenine and 1-(2′-deoxy-2′-fluoro-β-d-arabinofuranosyl)-5-iodouracil on seal herpesvirus (phocid herpesvirus 1) infection in vitro Osterhaus, Albert D.M.E.
 1987
 4 p. 221-226
6 p.
 article
162 Simian and feline immunodeficiency viruses: Animal lentivirus models for evaluation of AIDS vaccines and antiviral agents Gardner, Murray B.
 1991
 4 p. 267-286
20 p.
 article
163 Stereoelectronic properties of five anti-HSV-1 2′-deoxynucleosides analogues with heterocyclic substituents in the 5-position: A comparison with BVDU Olivier, Anne
 1994
 4 p. 289-304
16 p.
 article
164 Subject index 1995
 4 p. 455-457
3 p.
 article
165 Subject index 1995
 4 p. 435-438
4 p.
 article
166 Subject index 1994
 4 p. 370-372
3 p.
 article
167 Subject index 1991
 4 p. 365-367
3 p.
 article
168 Subject index 1992
 4 p. 367-369
3 p.
 article
169 Subject index 1993
 4 p. 335-337
3 p.
 article
170 Subject index 1991
 4 p. 353-355
3 p.
 article
171 Subject index 1992
 4 p. 357-359
3 p.
 article
172 Subject index 1993
 4 p. 375-377
3 p.
 article
173 Subject index 1993
 4 p. 353-355
3 p.
 article
174 Subject index 1995
 4 p. 373-376
4 p.
 article
175 Suppression of murine retroviral disease by 2′,3′-didehydro-2′,3′-dideoxythymidine (D4T) Sidwell, Robert W.
 1992
 4 p. 313-324
12 p.
 article
176 Synergism between anti-rhinovirus antivirals: Various human interferons and a number of synthetic compounds Ahmad, Abdul Latif Mohammad
 1986
 4 p. 241-252
12 p.
 article
177 Synergistic activities of type I (α, β) and type II (γ) murine interferons Zerial, Aurelio
 1982
 4 p. 227-239
13 p.
 article
178 Synergistic drug interactions of an HIV-1 protease inhibitor with AZT in different in vitro models of HIV-1 infection Lambert, D.M.
 1993
 4 p. 327-342
16 p.
 article
179 Synergistic inhibition of human immunodeficiency virus type 1 (HIV-1) replication in vitro by 1-[(2-hydroxyethoxy)methyl]-6-phenylthiothymine (HEPT) and recombinant alpha interferon Ito, Masahiko
 1991
 4 p. 323-330
8 p.
 article
180 Synthesis and antiviral properties of carbocyclic 3′-oxa-2′,3′-dideoxyguanosine and its 7-deazaguanosine analogue Chen, Xing
 1993
 4 p. 333-345
13 p.
 article
181 Synthesis of 5-[1-hydroxy (or methoxy)-2,2-dihaloethyl]-2′-deoxyuridines with antiviral and cytotoxic activity Kumar, Rakesh
 1994
 4 p. 315-325
11 p.
 article
182 The implications of resistance to antiviral agents for herpesvirus drug targets and drug therapy Coen, Donald M.
 1991
 4 p. 287-300
14 p.
 article
183 The influence of dextran sulfate on influenza A virus fusion with erythrocyte membranes Herrmann, Andreas
 1992
 4 p. 295-311
17 p.
 article
184 The interaction of monoclonal antibodies directed against envelope glycoprotein E1 of Sindbis virus with virus-infected cells Chanas, Alex C.
 1982
 4 p. 191-201
11 p.
 article
185 The question of aids 1986
 4 p. 253-
1 p.
 article
186 The ribonucleotide reductase inhibitor (E)-2′-fluoromethylene-2′-deoxycytidine (MDL 101,731): a potential topical therapy for herpes simplex virus infection Bridges, C.Gordon
 1995
 4 p. 325-334
10 p.
 article
187 The role of tumor necrosis factor in viral disease Czarniecki, Christine W.
 1993
 4 p. 223-258
36 p.
 article
188 Thiosemicarbazones of 2-acetylpyridine, 2-acetylquinoline, 1-acetylisoquinoline, and related compounds as inhibitors of herpes simplex virus in vitro and in a cutaneous herpes guinea pig model Shipman Jr., Charles
 1986
 4 p. 197-222
26 p.
 article
189 Under the volcano: Biomedical science and the third world 1988
 4 p. 283-
1 p.
 article
190 Use of a Flavivirus RNA-dependent RNA polymerase assay to investigate the antiviral activity of selected compounds Bartholomeusz, A.
 1994
 4 p. 341-350
10 p.
 article
191 Use of human monocytes in the evaluation of antiviral drugs: Quantitation of HSV-1 cytopathic effects Lazdins, Janis
 1990
 4 p. 175-186
12 p.
 article
192 Valacyclovir: a review of its antiviral activity, pharmacokinetic properties, and clinical efficacy Beutner, Karl R.
 1995
 4 p. 281-290
10 p.
 article
193 Vertebrate brains contain a broadly active antiviral substance Singh, Indra P.
 1995
 4 p. 375-388
14 p.
 article
194 VI international symposium on viral hepatitis 1993
 4 p. 369-
1 p.
 article
195 Viral glycoprotein metabolism as a target for antiviral substances Klenk, Hans-Dieter
 1982
 4 p. 177-190
14 p.
 article
196 Viral haemorrhagic fevers: properties and prospects for treatment and prevention Howard, C.R.
 1984
 4 p. 169-185
17 p.
 article
197 Viruses and cancer Billiau, A.
 1985
 4 p. 255-
1 p.
 article
198 Yucca leaf protein (YLP) stops the protein synthesis in HSV-infected cells and inhibits virus replication Hayashi, Kyoko
 1992
 4 p. 323-333
11 p.
 article
                             198 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands